TrialJournal of clinical oncology : official journal of the American Society of Clinical Oncology2017

Randomized, Noncomparative, Phase II Trial of Early Switch From Docetaxel to Cabazitaxel or Vice Versa, With Integrated Biomarker Analysis, in Men With Chemotherapy-Naïve, Metastatic, Castration-Resistant Prostate Cancer.

Emmanuel S Antonarakis et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.